BridgeBio is significantly advanced its progress of a novel therapy for amyloid heart disease, employing the compound. Early clinical data indicates potential benefits for patients suffering with this severe condition. The effort underscores BridgeBio's commitment to managing significant medical demands in the heart disease field. Attruby: BridgeB